Document 0719 DOCN M9550719 TI A preliminary evaluation of a prototype western blot confirmatory test kit for syphilis. DT 9505 AU Young H; Walker PJ; Merry D; Mifsud A; Department of Medical Microbiology, Edinburgh University Medical; School, Scotland. SO Int J STD AIDS. 1994 Nov-Dec;5(6):409-14. Unique Identifier : AIDSLINE MED/95151863 AB A prototype Western blot kit was evaluated as a confirmatory test for syphilis using 131 sera characterized by other serological tests for syphilis. There were 114 treponemal sera (including 94 cases of early syphilis, 83 of which were untreated) and 17 non-treponemal problem sera (11 gave false positive reactions on screening with the TmpA recombinant antigen enzyme immunoassay (EIA), 3 gave false positive fluorescent treponemal antibody absorbed (FTA-abs) tests, and 3 false positive Captia Syphilis G EIA results). Based on the manufacturer's criteria of reactivity in multiple bands for designating a positive result the Western blot test gave a sensitivity of 99.1% (113/114) and a specificity of 88.2% (15/17) when indeterminate reactions were scored positive and 98.2% (112/114) and 100% (17/17) when indeterminate reactions were scored negative. Sensitivity was high in both treated and untreated infection. Corresponding sensitivities for the TPHA and FTA-abs when equivocal reactions were scored negative were 97.5% (111/114) and 99.1% (113/114). The high sensitivity of the FTA-abs in this study is probably due to the large number of untreated primary infections. Our results with the Western blot, confirm earlier studies using 'in-house' test systems and, support a role for a commercial Western blot test in the confirmatory diagnosis of syphilis. Further studies are required to confirm the high specificity and sensitivity of the kit in a larger series including a wider variety of non-treponemal cases as well as patients with untreated and treated infection. DE Blotting, Western/*INSTRUMENTATION Evaluation Studies False Positive Reactions Human Reagent Kits, Diagnostic Sensitivity and Specificity Syphilis/*DIAGNOSIS Syphilis Serodiagnosis CLINICAL TRIAL JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).